New combo attack on aggressive sarcomas tests safety limits
NCT ID NCT04037527
Summary
This early-stage trial tested the safety of combining two chemotherapy drugs (gemcitabine and docetaxel) with radiation before surgery for adults with large, aggressive soft tissue sarcomas in the arms or legs. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also wanted to see how this treatment combination affected the immune system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.